Skip to main content

Animations

MJFF Publications

5011 - 5020 of 9034 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2021
  • Facial Analysis Software Helps Screen for Parkinson's Disease
    2022
    Summary Details
    RESTRICTED
    Title: Facial Analysis Software Helps Screen for Parkinson's Disease
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000817640.88538.ff
    Citation Count: 0
  • Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-Encephalitis
    2022
    Summary Details
    RESTRICTED
    Title: Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-Encephalitis
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903424.19914.85
    Citation Count: 0
  • Summary Details
    OPEN
    Title: “Stretched Slinky” Sign
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000200075
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging Study
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000200072
    Citation Count: 4
  • Drug News
    2022
    Summary Details
    RESTRICTED
    Title: Drug News
    Journal Name: Nursing
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nurse.0000803500.30920.0c
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?
    Journal Name: Age and Ageing
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1093/ageing/afab242
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awac176
    Citation Count: 143
  • Summary Details
    OPEN
    Title: ATXN2 intermediate expansions in amyotrophic lateral sclerosis
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awac167
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Hierarchical Denoising of Ordinal Time Series of Clinical Scores
    Journal Name: IEEE Journal of Biomedical and Health Informatics
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/jbhi.2022.3163126
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab374
    Citation Count: 25
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.